JNJ-38877618 is a potent, highly selective, orally bioavailable Met kinase inhibitor with IC50s of 2 and 3 nM for wild type and mutant Met, respectively.
规格 | 价格 | 会员价 | 库存 | 数量 | |||
---|---|---|---|---|---|---|---|
{[ item.pr_size ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price) ]} |
{[ getRatePrice(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解
描述 | JNJ-38877618 is a potent, highly selective, orally bioavailable Met kinase inhibitor with IC50s of 2 and 3 nM for wild type and mutant Met, respectively. |
NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
NCT01964872 | Healthy Volunteers | Phase 1 | Completed | - | United Kingdom ... 展开 >> Nottingham, United Kingdom 收起 << |
NCT03138083 | Neoplasms | Phase 1 Phase 2 | Recruiting | December 2020 | France ... 展开 >> lNSTITUT GUSTAVE ROUSSY Recruiting Villejuif, France, 94805 Contact: Eric Angevin, MD Netherlands Erasmus Mc Recruiting Rotterdam, Netherlands, 3000 CA Contact: Martijn Lolkema, MD/PhD Universitair Medisch Centrum Utrecht Recruiting Utrecht, Netherlands, 3584 CX Contact: Filip De Vos, MD United Kingdom University College London Hospitals Nhs Foundation Trust Recruiting London, United Kingdom, NW1 2BU Contact: Martin Forster, MD The Christie Nhs Foundation Trust Recruiting Manchester, United Kingdom, M20 4BX Contact: Matthew G Krebs, MD PhD MRCP Matthew.Krebs@christie.nhs.uk The Newcastle Upon Tyne Hospitals Nhs Foundation Trust Recruiting Newcastle upon Tyne, United Kingdom, NE7 7DN Contact: Ruth Plummer, MD Ruth.Plummer@newcastle.ac.uk University of Oxford, Department of Oncology Recruiting Oxford, United Kingdom, OX3 7LE Contact: Sarah P Blagden, MD +441865227212 sarah.blagden@oncology.ox.ac.uk 收起 << |
计算器 | ||||
存储液制备 | ![]() |
1mg | 5mg | 10mg |
1 mM 5 mM 10 mM |
2.67mL 0.53mL 0.27mL |
13.36mL 2.67mL 1.34mL |
26.71mL 5.34mL 2.67mL |
CAS号 | 943540-74-7 |
分子式 | C20H12F2N6 |
分子量 | 374.35 |
SMILES Code | FC(C1=CC=C2N=CC=CC2=C1)(F)C3=NN=C4C=CC(C5=CC=NC=C5)=NN43 |
MDL No. | MFCD31657377 |
别名 | |
运输 | 蓝冰 |
存储条件 |
In solvent -20°C:3-6个月-80°C:12个月 Pure form Sealed in dry, 2-8°C |
溶解方案 |
请根据您的动物给药指南选择适当的溶解方案。 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|